PRIMARY STUDY
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Key Findings: The currently available preclinical and clinical evidence points to CBD as a promising treatment strategy for these patient populations.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Brazil
Year of Pub: 2019
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Citation: Loss CM, et al. Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?. Front Pharmacol. 2020; 11:635763. doi: 10.3389/fphar.2020.635763
Authors: Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA, Hallak JEC, Abílio VC
